Fulltext
The full text is available in PDF.
International Cardiovascular Research Journal
An annual journal in scientific affiliation with the Cardiovascular Research Center, Shiraz University of Medical Sciences
e-ISSN 2251-9149
p-ISSN 2251-9130
Image Credit:Int Cardiovasc Res J
Outline
Suppression of Myocardial Injury Markers following Percutaneous Coronary Interventions by Pre-treatment with Carvedilol
Authors
1Emam Ali Cardiovascular Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
*Corresponding Author: Corresponding author: Abdolrasoul Moloudi, Emam Ali Cardiovascular Center, Kermanshah University of Medical Sciences, Kermanshah, Iran Email: amouloudi@yahoo.com
Published online:Sep 30, 2012
Article type:Research Article
Received:May 16, 2017
Accepted:Jul 09, 2012
How to Cite: Moloudi A, Sabzi F, Rashidi S. Suppression of Myocardial Injury Markers following Percutaneous Coronary Interventions by Pre-treatment with Carvedilol. Int Cardiovasc Res J. 2017;6(3):e12805. doi:
Abstract
Background: Retrospective studies and clinical trials have indicated that β-receptor blockers have an influential role in improving survival and reducing risk of recurrent infarction in patients with myocardial infarction. However, there is still controversy regarding the effects of β-receptor blockers on the markers of myocardial infarction following percutaneous coronary interventions (PCI).
Objective: The aim of this study was to evaluate the pre-treatment effect of Carvedilol on markers of myocardial injury in patients undergoing elective PCI.
Method and Materials: In this clinical trial patients undergoing elective PCI were categorized randomly in the Carvedilol group including 100 patients who received two doses of 12.5 mg, 6 and 12 hours prior to PCI, and the control group (105 patients). Blood samples were obtained to analyse cardiac biomarker, 12 and 24 hours after PCI.
Results: The clinical features were not significantly different between the two groups. A increase in the level of Troponin I was observed in the control group 24 hours following PCI (P=0.042), whereas this rise in troponin I was slight and insignificant in the Carvedilol group (P>0.05). some difference was observed between the two groups in regard to the level of CPK-MB after PCI (P=0.041).
Conclusion: The findings of our study indicate that pre-treatment with Carvedilol confers cardio-protection by limiting the rise of markers of myocardial injury following PCI.
Highlights
References
- 1.The references are available in PDF.
Copyright
© 2017, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
20
Apr
2022
Comparing the Effect of a Preprocedural Loading Dose of Atorvastatin vs. Rosuvastatin on the Prevalence of No-reflow and Low TIMI Flow in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Intervention
Naser Aslanabadi,
Naser Khalili,
Reza Hajizadeh,
Dorsa Kavandi
Aslanabadi N, Khalili N, Hajizadeh R, Kavandi D. Comparing the Effect of a Preprocedural Loading Dose of Atorvastatin vs. Rosuvastatin on the Prevalence of No-reflow and Low TIMI Flow in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Intervention. Shiraz E-Med J. 2022;23(7):e119477. doi: https://doi.org/10.5812/semj-119477
30
Jun
2011
Prognostic Value of Troponin T after Elective Percutaneous Coronary Intervention
A Ghaemian,
safoora Masoumi,
RA Mohammadpour
Ghaemian A, Masoumi S, Mohammadpour R. Prognostic Value of Troponin T after Elective Percutaneous Coronary Intervention. Int Cardiovasc Res J. 2017;5(1):e14234. doi:
31
Dec
2019
The Potential Effect of Intravenous Calcitriol on the Ischemia-Reperfusion Process and Inflammatory Biomarkers in Patients Following Percutaneous Coronary Intervention (PCI)
Farzaneh Dastan,
Jamshid Salamzadeh,
Saeed Alipour-Parsa,
Babak Sharif Kashani,
Mohammad Mahdi Hashempour
Dastan F, Salamzadeh J, Alipour-Parsa S, Sharif Kashani B, Hashempour MM. The Potential Effect of Intravenous Calcitriol on the Ischemia-Reperfusion Process and Inflammatory Biomarkers in Patients Following Percutaneous Coronary Intervention (PCI). Iran J Pharm Res. 2019;18(Suppl1):e124453. doi: https://doi.org/10.22037/ijpr.2019.112469.13778
30
Sep
2014
Comparing the Therapeutic Effects of Carvedilol and Metoprolol on Prevention of Atrial Fibrillation after Coronary Artery Bypass Surgery, a Double-Blind Study
Rozita Jalalian,
Rahman Ghafari,
Peyman Ghazanfari
Jalalian R, Ghafari R, Ghazanfari P. Comparing the Therapeutic Effects of Carvedilol and Metoprolol on Prevention of Atrial Fibrillation after Coronary Artery Bypass Surgery, a Double-Blind Study. Int Cardiovasc Res J. 2017;8(3):e11088. doi:
31
Jul
2015
Effect of Melatonin on Cardiac Injury after Primary Percutaneous Coronary Intervention: a Randomized Controlled Trial
Padideh Ghaeli,
Shaghayegh Vejdani,
Atefeh Ariamanesh,
Azita Hajhossein Talasaz
Ghaeli P, Vejdani S, Ariamanesh A, Hajhossein Talasaz A. Effect of Melatonin on Cardiac Injury after Primary Percutaneous Coronary Intervention: a Randomized Controlled Trial. Iran J Pharm Res. 2015;14(3):e125303. doi: https://doi.org/10.22037/ijpr.2015.1677
More by these authors
Cited by
- Scopus by DOI: 0
Last Update: 2 weeks ago
- Scopus by Title: 3
Last Update: 2 weeks ago
- Scopus by Title (Ref): 3
Last Update: 2 weeks ago
- CrossRef: 0
Last Update: 2 hours ago
- OpenAlex: 0
Last Update: 5 hours ago
- OpenCitations: 0
Last Update: 5 days ago
Comments
Number of Comments:0Indexed in
